Trillium Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Buy
729
+45
+7% +$16K 0.01% 216
2025
Q4
$224K Sell
684
-227
-25% -$72K 0.01% 226
2025
Q3
$257K Hold
911
0.01% 220
2025
Q2
$254K Hold
911
0.01% 219
2025
Q1
$284K Hold
911
0.01% 209
2024
Q4
$237K Buy
911
+37
+4% +$11K 0.01% 227
2024
Q3
$281K Hold
874
0.01% 220
2024
Q2
$273K Sell
874
-67
-7% -$19.7K 0.01% 224
2024
Q1
$267K Sell
941
-63
-6% -$18.4K 0.01% 223
2023
Q4
$289K Hold
1,004
0.01% 215
2023
Q3
$270K Sell
1,004
-12
-1% -$3K 0.01% 216
2023
Q2
$225K Hold
1,016
0.01% 212
2023
Q1
$243K Hold
1,016
0.01% 211
2022
Q4
$267K Sell
1,016
-9
-0.9% -$2.41K 0.01% 222
2022
Q3
$231K Hold
1,025
0.01% 219
2022
Q2
$249K Sell
1,025
-175
-15% -$42.9K 0.01% 217
2022
Q1
$290K Sell
1,200
-320
-21% -$73.5K 0.01% 228
2021
Q4
$342K Sell
1,520
-7
-0.5% -$1.48K 0.01% 228
2021
Q3
$325K Sell
1,527
-212
-12% -$48.8K 0.01% 219
2021
Q2
$424K Sell
1,739
-10
-0.6% -$2.46K 0.01% 213
2021
Q1
$435K Hold
1,749
0.01% 211
2020
Q4
$402K Hold
1,749
0.01% 211
2020
Q3
$445K Sell
1,749
-41
-2% -$10.2K 0.02% 195
2020
Q2
$422K Sell
1,790
-1,110
-38% -$253K 0.02% 201
2020
Q1
$588K Hold
2,900
0.03% 187
2019
Q4
$699K Sell
2,900
-1,106
-28% -$244K 0.03% 192
2019
Q3
$775K Buy
4,006
+2,774
+225% +$532K 0.04% 192
2019
Q2
$227K Sell
1,232
-29
-2% -$5.19K 0.01% 224
2019
Q1
$240K Hold
1,261
0.01% 226
2018
Q4
$245K Hold
1,261
0.01% 221
2018
Q3
$261K Hold
1,261
0.01% 225
2018
Q2
$233K Hold
1,261
0.01% 226
2018
Q1
$215K Sell
1,261
-405
-24% -$74.3K 0.01% 227
2017
Q4
$290K Hold
1,666
0.02% 210
2017
Q3
$311K Sell
1,666
-34
-2% -$6.02K 0.02% 203
2017
Q2
$293K Sell
1,700
-247
-13% -$40.2K 0.02% 205
2017
Q1
$319K Sell
1,947
-348
-15% -$57.8K 0.02% 193
2016
Q4
$336K Sell
2,295
-1,549
-40% -$233K 0.02% 195
2016
Q3
$641K Sell
3,844
-35,015
-90% -$5.92M 0.04% 177
2016
Q2
$5.91M Sell
38,859
-28,158
-42% -$4.38M 0.39% 93
2016
Q1
$10M Sell
67,017
-1,479
-2% -$220K 0.67% 61
2015
Q4
$11.1M Sell
68,496
-421
-0.6% -$66.2K 0.75% 52
2015
Q3
$9.53M Sell
68,917
-744
-1% -$117K 0.67% 58
2015
Q2
$10.7M Sell
69,661
-52,763
-43% -$8.45M 0.69% 53
2015
Q1
$19.6M Sell
122,424
-303
-0.2% -$47.7K 1.27% 19
2014
Q4
$19.5M Buy
122,727
+4,736
+4% +$738K 1.33% 12
2014
Q3
$16.6M Sell
117,991
-1,231
-1% -$161K 1.43% 12
2014
Q2
$14.1M Buy
119,222
+13,805
+13% +$1.6M 1.21% 24
2014
Q1
$13M Buy
105,417
+3,189
+3% +$387K 1.22% 23
2013
Q4
$11.7M Buy
102,228
+17,678
+21% +$2.01M 1.15% 24
2013
Q3
$9.46M Sell
84,550
-37,522
-31% -$4.07M 1.05% 33
2013
Q2
$12M Buy
+122,072
New +$12.7M 1.49% 18

Other funds holding AMGN

Trillium Asset Management's AMGN Position: Q1 2026 in Review

Trillium Asset Management increased its Amgen (AMGN) stake by 6.6% in Q1 2026, buying an estimated $16K and bringing the position to 729 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #216.

Trillium Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.6M in Q1 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Trillium Asset Management held 729 shares of Amgen worth $256K as of Q1 2026.
  • Trillium Asset Management bought 45 Amgen shares in Q1 2026, an estimated $16K.
  • Amgen made up 0.01% of Trillium Asset Management's portfolio in Q1 2026, its #216 holding.
  • Trillium Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Trillium Asset Management's Amgen position peaked at $19.6M in Q1 2015.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.